One key technology 4SM are investigating is plasma technology. Capable of producing chemicals including nitric oxide and other radicals that can sterilise and deactivate bacteria and heal wounds, the temperature and surface energy delivery of plasma technologies can also be controlled in order to reduce epidermal and superficial dermal thickness.
The team recently created a hand-held plasma device, which can remove the upper layer of dermis and sterilise skin treatment areas. Application of the technology includes wrinkle removal and fine line reductions, treatment of diabetic ulcers and open wounds as well as trauma-related operations like managing acute bleeding.
Dr Tom Frame, founder and CEO of 4SM said, "We have had significant results across a range of histopathology studies and microbiology evaluation, which demonstrates a high level of efficacy across our commercial applications."
For the full news story follow this link: